These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35006660)

  • 41. Resident Physicians Choices of Anticoagulation for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation.
    Oqab Z; McIntyre WF; Quinn KL; Lamb T; Quadros K; Yazdan-Ashoori P; van Oosten E; Chu K; Lamba J; Barake W; Mohajer K; Marr JN; Baranchuk A
    Can J Cardiol; 2016 Jun; 32(6):824-8. PubMed ID: 26652126
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group.
    Goldstein LB; Adams R; Alberts MJ; Appel LJ; Brass LM; Bushnell CD; Culebras A; DeGraba TJ; Gorelick PB; Guyton JR; Hart RG; Howard G; Kelly-Hayes M; Nixon JV; Sacco RL; ;
    Circulation; 2006 Jun; 113(24):e873-923. PubMed ID: 16785347
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mixed treatment comparison meta-analysis of aspirin, warfarin, and new anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation.
    Assiri A; Al-Majzoub O; Kanaan AO; Donovan JL; Silva M
    Clin Ther; 2013 Jul; 35(7):967-984.e2. PubMed ID: 23870607
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN89345269].
    Mant JW; Richards SH; Hobbs FD; Fitzmaurice D; Lip GY; Murray E; Banting M; Fletcher K; Rahman J; Allan T; Raftery J; Bryan S;
    BMC Cardiovasc Disord; 2003 Aug; 3():9. PubMed ID: 12939169
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk of Ischemic Stroke in High Risk Atrial Fibrillation Patients during Periods of Warfarin Discontinuation for Surgical Procedures.
    Qureshi AI; Jahangir N; Malik AA; Afzal MR; Orfi F; Suri MF
    Cerebrovasc Dis; 2016; 42(5-6):346-351. PubMed ID: 27322535
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
    Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
    JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial.
    Lancet; 1996 Sep; 348(9028):633-8. PubMed ID: 8782752
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel Oral Anticoagulant Use Among Patients With Atrial Fibrillation Hospitalized With Ischemic Stroke or Transient Ischemic Attack.
    Patel PA; Zhao X; Fonarow GC; Lytle BL; Smith EE; Xian Y; Bhatt DL; Peterson ED; Schwamm LH; Hernandez AF
    Circ Cardiovasc Qual Outcomes; 2015 Jul; 8(4):383-92. PubMed ID: 26058721
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
    Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel oral anticoagulants in secondary prevention of stroke.
    Diener HC; Easton JD; Hankey GJ; Hart RG
    Best Pract Res Clin Haematol; 2013 Jun; 26(2):131-9. PubMed ID: 23953901
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation.
    Freeman JV; Zhu RP; Owens DK; Garber AM; Hutton DW; Go AS; Wang PJ; Turakhia MP
    Ann Intern Med; 2011 Jan; 154(1):1-11. PubMed ID: 21041570
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Secondary prevention of stroke in patients with nonvalvular atrial fibrillation: optimal intensity of anticoagulation.
    Yasaka M; Yamaguchi T
    CNS Drugs; 2001; 15(8):623-31. PubMed ID: 11524034
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Current trial-associated outcomes with warfarin in prevention of stroke in patients with nonvalvular atrial fibrillation: a meta-analysis.
    Agarwal S; Hachamovitch R; Menon V
    Arch Intern Med; 2012 Apr; 172(8):623-31; discussion 631-3. PubMed ID: 22450212
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stroke prevention in atrial fibrillation: a systematic review.
    Lip GY; Lane DA
    JAMA; 2015 May; 313(19):1950-62. PubMed ID: 25988464
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Direct oral anticoagulants: key considerations for use to prevent stroke in patients with nonvalvular atrial fibrillation.
    Ment J
    Vasc Health Risk Manag; 2015; 11():317-32. PubMed ID: 26089678
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Atrial fibrillation anticoagulation care in a large urban family medicine practice.
    Valentinis A; Ivers N; Bhatia S; Meshkat N; Leblanc K; Ha A; Morra D
    Can Fam Physician; 2014 Mar; 60(3):e173-9. PubMed ID: 24627401
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk factors for cerebral ischemic events in patients with atrial fibrillation on warfarin for stroke prevention.
    Paciaroni M; Agnelli G; Ageno W; Caso V; Corea F; Lanari A; Alberti A; Previdi P; Fedele M; Manina G; Vedovati C; Venti M; Billeci AM; Batta M; Galli L; Silvestrelli G
    Atherosclerosis; 2010 Oct; 212(2):564-6. PubMed ID: 20599199
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated.
    Gladstone DJ; Bui E; Fang J; Laupacis A; Lindsay MP; Tu JV; Silver FL; Kapral MK
    Stroke; 2009 Jan; 40(1):235-40. PubMed ID: 18757287
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stroke prevention in patients with atrial fibrillation in France: comparative cost-effectiveness of new oral anticoagulants (apixaban, dabigatran, and rivaroxaban), warfarin, and aspirin.
    Lanitis T; Cotté FE; Gaudin AF; Kachaner I; Kongnakorn T; Durand-Zaleski I
    J Med Econ; 2014 Aug; 17(8):587-98. PubMed ID: 24831811
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Time Trends of Aspirin and Warfarin Use on Stroke and Bleeding Events in Chinese Patients With New-Onset Atrial Fibrillation.
    Guo Y; Wang H; Tian Y; Wang Y; Lip GYH
    Chest; 2015 Jul; 148(1):62-72. PubMed ID: 25501045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.